Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Annals of Medicine|April 28, 2025
PPAR-mediated reduction of lipid accumulation in hepatocytes involves the autophagy-lysosome-mitochondrion axisFederica Cetti, Alice Ossoli, Carola Garavaglia, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2010
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivoIlaria Zanotti, Matteo Pedrelli, Francesco Potì, et al.FEBS Letters|October 21, 2006
Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotectionStefano Bellosta, Monica Gomaraschi, Monica Canavesi, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|April 5, 2011
Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulationsMonica Gomaraschi, Laura Obici, Sara Simonelli, et al.The Journal of Pharmacology and Experimental Therapeutics|November 29, 2007
Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptidesMonica Gomaraschi, Laura Calabresi, Giuseppe Rossoni, et al.Atherosclerosis|May 20, 2008
The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarctionMonica Gomaraschi, Gianfranco Sinagra, Laura Vitali Serdoz, et al.Circulation|October 31, 2007
Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutantMonica Gomaraschi, Damiano Baldassarre, Mauro Amato, et al.Scientific Reports|February 4, 2018
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell ProliferationMassimiliano Ruscica, Margherita Botta, Nicola Ferri, et al.Biofactors (Oxford, England)|May 17, 2022
HDL-mediated reduction of cholesterol content inhibits the proliferation of prostate cancer cells induced by LDL: Role of ABCA1 and proteasome inhibitionAlice Ossoli, Eleonora Giorgio, Federica Cetti, et al.Vascular Pharmacology|July 3, 2015
Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndromeMonica Gomaraschi, Alice Ossoli, Maria Pia Adorni, et al.Pageof 6